(IMMU) |
| 0 (0%) 02-22 04:44 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 102.70 |
| Resistance 1: | 87.93 |
| Pivot price: | 86.84 |
| Support 1: | 86.02 |
| Support 2: | 84.84 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | -1.101 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 16 Feb 2026
Mendus (Q4 review): CML a New Value Driver - TradingView
Fri, 13 Feb 2026
Mendus:Vididencel set for a defining year - Research Tree
Wed, 11 Feb 2026
IMMU: Strong clinical progress and financing position support broad expansion in AML and CML - TradingView
Wed, 11 Feb 2026
IMMU: Strong clinical progress and new funding, but further capital needed beyond early 2027 - TradingView
Tue, 11 Nov 2025
Fuzon comes back after six years with new vocalist - The Express Tribune
Thu, 06 Nov 2025
Mikku Immu blends health and taste with fermented ingredients, vitamin C and 4,000mg of fibre - Mini Me Insights
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
